Workflow
UltraMist Consumables
icon
Search documents
SANUWAVE Health Inc(SNWV) - 2025 Q2 - Earnings Call Presentation
2025-08-08 12:30
Financial Performance - Revenue for Q2 2025 reached $10.2 million, a 42% increase compared to $7.2 million in Q2 2024 [13] - Gross profit for Q2 2025 was $8.0 million, up 52% from $5.2 million in Q2 2024 [13] - Gross margin improved to 78.3% in Q2 2025, a 513 basis point increase from 73.2% in Q2 2024 [13] - Operating income for Q2 2025 was $1.9 million, a 6% decrease compared to $2.0 million in Q2 2024 [13] - Adjusted EBITDA for the three months ended June 30, 2025, was $3.37 million, compared to $1.457 million for the same period in 2024 [18] UltraMIST Performance - UltraMIST saw continuous revenue growth in 2024 and strong year-over-year growth in Q2 2025 [20] - The company had 1,261 UltraMIST systems in the field at the end of Q2 2025 [22] - 116 UltraMIST systems were sold in Q2 2025, compared to 72 in Q2 2024 and 98 in Q1 2025 [22] Revenue Guidance - The company projects Q3 2025 revenue to be between $12 million and $12.7 million, compared to $9.36 million in Q3 2024 [25] - The company targets full-year 2025 revenue to be between $48 million and $50 million, representing a 47-53% increase compared to $32.6 million in FY 2024 [25]